Lymphatic chylomicron size is inversely related to biliary phospholipid secretion in mice.
Biliary phospholipids (PL) stimulate dietary fat absorption by facilitating intraluminal lipid solubilization and by providing surface components for chylomicron (CM) assembly. Impaired hepatic PL availability induces secretion of large very-low-density lipoproteins, but it is unclear whether CM size depends on biliary PL availability. Biliary PL secretion is absent in multidrug resistance protein 2-deficient (Mdr2(-/-)) mice, whereas it is strongly increased in essential fatty acid (EFA)-deficient mice. We investigated lymphatic CM size and composition in mice with absent (Mdr2(-/-)) or enhanced (EFA deficient) biliary PL secretion and in their respective controls under basal conditions and during enteral lipid administration. EFA deficiency was induced by feeding mice a high-fat, EFA-deficient diet for 8 wk. Lymph was collected by mesenteric lymph duct cannulation with or without intraduodenal lipid administration. Lymph was collected in 30-min fractions for up to 4 h, and lymphatic lipoprotein size was determined by dynamic light-scattering techniques. Lymph lipoprotein subfractions were isolated by ultracentrifugation, and lipid composition was measured. Lymphatic CMs were significantly larger in Mdr2(-/-) mice than in Mdr2(+/+) controls either without (+50%) or with (+25%) enteral lipid administration, and molar core-surface ratios were increased [triglyceride (TG)-to-PL ratio: 4.4 +/- 1.4 in Mdr2(-/-) mice vs. 2.7 +/- 0.8 in Mdr2(+/+) mice, P < 0.001]. In contrast, EFA-deficient mice secreted lipoproteins into lymph that were significantly smaller than in EFA-sufficient controls (173 +/- 32 vs. 236 +/- 47 nm), with correspondingly decreased core-surface ratios (TG-to-PL ratio: 3.0 +/- 1.0 in EFA-deficient mice vs. 6.0 +/- 1.9 in EFA-sufficient mice, P < 0.001). CM size increased during fat absorption in both EFA-deficient and EFA-sufficient mice, but the difference between the groups persisted. In conclusion, the present results strongly suggest that the availability of biliary PL is a major determinant of the size of intestinally produced lipoproteins both under basal conditions and during lipid absorption. Altered CM size may have physiological consequences for postprandial CM processing.
Werner
Anniek
A
Pediatric Gastroenterology, Department of Pediatrics, Groningen University Institute for Drug Exploration, University Medical Center Groningen, University of Groningen, The Netherlands. a.werner@med.umcg.nl
Havinga
Rick
R
Perton
Frank
F
Kuipers
Folkert
F
Verkade
Henkjan J
HJ
D000818:Animals; D001652:Bile Ducts / Q000378:metabolism*; D002914:Chylomicrons / Q000737:chemistry / Q000378:metabolism* / Q000648:ultrastructure*; D005228:Fatty Acids, Essential / Q000378:metabolism*; D008198:Lymph Nodes / Q000378:metabolism*; D051379:Mice; D010743:Phospholipids / Q000378:metabolism*; D013223:Statistics as Topic
D002914:Chylomicrons; D005228:Fatty Acids, Essential; D010743:Phospholipids